1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Scherf, T.
Kasher, R.
Balass, M.
Fridkin, M.
Fuchs, S.
Katchalski-Katzir, E.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
98
6629
10.1073/PNAS.111164298
11381118
A Beta-Hairpin Structure in a 13-mer Peptide that Binds Alpha-Bungarotoxin with High Affinity and Neutralizes its Toxicity
2001
UK
Chem.Biol.
CBOLE2
2050
1074-5521
8
147
10.1016/S1074-5521(00)90063-2
11251289
Design and Synthesis of Peptides that Bind A-Bungarotoxin with High Affinity
2001
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
ALPHA-NEUROTOXIN
8005.281
ALPHA-BUNGAROTOXIN
1
nat
polymer
A CHEMICALLY SYNTHESIZED PEPTIDE THAT INHIBITS A-BTX BINDING TO ACHR WITH AN IC50 OF 2 NM
1705.799
PEPTIDE
1
syn
polymer
LONG NEUROTOXIN 1, BGTX, ALPHA-BTX, A-BTX
HIGH AFFINITY PEPTIDE
no
no
IVCHTTATSPISAVTCPPGENLCYRKMWCDAFCSSRGKVVELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRPG
IVCHTTATSPISAVTCPPGENLCYRKMWCDAFCSSRGKVVELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRPG
A
polypeptide(L)
no
no
WRYYESSLEPYPD
WRYYESSLEPYPD
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
MANY-BANDED KRAIT
sample
8616
BUNGARUS MULTICINCTUS
VENOM
repository
Initial release
Derived calculations
Other
Source and taxonomy
Version format compliance
1
0
2001-05-25
1
1
2015-09-30
ALPHA-BUNGAROTOXIN COMPLEXED WITH THE 185 - 196 FRAGMENT OF THE ALPHA-SUBUNIT OF THE TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR (NMR, 4 STRUCTURES)
SOLUTION NMR STRUCTURE OF THE COMPLEX OF ALPHA-BUNGAROTOXIN WITH A LIBRARY DERIVED PEPTIDE, 20 STRUCTURES
A BETA-HAIRPIN STRUCTURE IN A 13-MER PEPTIDE THAT BINDS A-BUNGAROTOXIN WITH HIGH AFFINITY AND NEUTRALIZES ITS TOXICITY
NMR STRUCTURE OF THE COMPLEX BETWEEN A- BUNGAROTOXIN AND AMIMOTOPE OF THE NICOTINIC ACETILCHOLINE RECEPTOR
NMR STRUCTURE OF THE COMPLEX BETWEEN A- BUNGAROTOXIN AND AMIMOTOPE OF THE NICOTINIC ACETILCHOLINE RECEPTOR
SOLUTION NMR STRUCTURE OF THE COMPLEX OF ALPHA-BUNGAROTOXIN WITH A LIBRARY DERIVED PEPTIDE, NMR, MINIMIZED AVERAGE STRUCTURE
SHEET
DETERMINATION METHOD: KABSCH AND SANDER ALGORITHM
STRAND: S1A 1; STRANDS S2D & S2E FORM B-HAIRPIN WITHIN THE
BOUND PEPTIDE, THAT COMBINES TO S2A-S2C TO FORM 5-STRANDED
INTERMOLECULAR BETA-SHEET.
PDBE
Y
PDBE
2001-04-05
REL
MIMOTOPE OF THE NICOTINIC ACETYLCHOLINE RECEPTOR
32630
SYNTHETIC CONSTRUCT
sample
THE PEPTIDE BINDS ALPHA-BUNGAROTOXIN AND THUS INHIBITS THE
BINDING OF THE TOXIN TO THE NICOTINIC RECEPTORS.
THE OBSERVED QUATERNARY STATE IS MONOMERIC IN SOLUTION WHILE
IN THE CRYSTAL STRUCTURES IT IS OBSERVED TO BE DIMERIC
THE STRUCTURES WERE DETERMINED USING STANDARD 2D 1H-NMR SPECTROSCOPY.
NO RESTRAINT VIOLATION
10
NOESY
HOHAHA
DQF-COSY
6
pH
AMBIENT
303
K
RMS DEVIATIONS FROM IDEAL VALUES: BOND LENGTH (A) 0.0033,ANGLES (DEG) 0.52 IMPROPERS (DEG) 0.45
DISTANCE GEOMETRY, DYNAMICAL SIMULATED ANNEALING
1
1MM COMPLEX IN 90% WATER,10% D2O
BRUNGER, ADAMS, CLORE, DELANO, GROS ET AL
refinement
CNS
0.9
structure solution
XWINNMR
structure solution
AURELIA
structure solution
CNS
500
Bruker
DMX
800
Bruker
DRX
ILE
1
n
1
ILE
1
A
VAL
2
n
2
VAL
2
A
CYS
3
n
3
CYS
3
A
HIS
4
n
4
HIS
4
A
THR
5
n
5
THR
5
A
THR
6
n
6
THR
6
A
ALA
7
n
7
ALA
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
PRO
10
n
10
PRO
10
A
ILE
11
n
11
ILE
11
A
SER
12
n
12
SER
12
A
ALA
13
n
13
ALA
13
A
VAL
14
n
14
VAL
14
A
THR
15
n
15
THR
15
A
CYS
16
n
16
CYS
16
A
PRO
17
n
17
PRO
17
A
PRO
18
n
18
PRO
18
A
GLY
19
n
19
GLY
19
A
GLU
20
n
20
GLU
20
A
ASN
21
n
21
ASN
21
A
LEU
22
n
22
LEU
22
A
CYS
23
n
23
CYS
23
A
TYR
24
n
24
TYR
24
A
ARG
25
n
25
ARG
25
A
LYS
26
n
26
LYS
26
A
MET
27
n
27
MET
27
A
TRP
28
n
28
TRP
28
A
CYS
29
n
29
CYS
29
A
ASP
30
n
30
ASP
30
A
ALA
31
n
31
ALA
31
A
PHE
32
n
32
PHE
32
A
CYS
33
n
33
CYS
33
A
SER
34
n
34
SER
34
A
SER
35
n
35
SER
35
A
ARG
36
n
36
ARG
36
A
GLY
37
n
37
GLY
37
A
LYS
38
n
38
LYS
38
A
VAL
39
n
39
VAL
39
A
VAL
40
n
40
VAL
40
A
GLU
41
n
41
GLU
41
A
LEU
42
n
42
LEU
42
A
GLY
43
n
43
GLY
43
A
CYS
44
n
44
CYS
44
A
ALA
45
n
45
ALA
45
A
ALA
46
n
46
ALA
46
A
THR
47
n
47
THR
47
A
CYS
48
n
48
CYS
48
A
PRO
49
n
49
PRO
49
A
SER
50
n
50
SER
50
A
LYS
51
n
51
LYS
51
A
LYS
52
n
52
LYS
52
A
PRO
53
n
53
PRO
53
A
TYR
54
n
54
TYR
54
A
GLU
55
n
55
GLU
55
A
GLU
56
n
56
GLU
56
A
VAL
57
n
57
VAL
57
A
THR
58
n
58
THR
58
A
CYS
59
n
59
CYS
59
A
CYS
60
n
60
CYS
60
A
SER
61
n
61
SER
61
A
THR
62
n
62
THR
62
A
ASP
63
n
63
ASP
63
A
LYS
64
n
64
LYS
64
A
CYS
65
n
65
CYS
65
A
ASN
66
n
66
ASN
66
A
PRO
67
n
67
PRO
67
A
HIS
68
n
68
HIS
68
A
PRO
69
n
69
PRO
69
A
LYS
70
n
70
LYS
70
A
GLN
71
n
71
GLN
71
A
ARG
72
n
72
ARG
72
A
PRO
73
n
73
PRO
73
A
GLY
74
n
74
GLY
74
A
TRP
75
n
1
TRP
75
B
ARG
76
n
2
ARG
76
B
TYR
77
n
3
TYR
77
B
TYR
78
n
4
TYR
78
B
GLU
79
n
5
GLU
79
B
SER
80
n
6
SER
80
B
SER
81
n
7
SER
81
B
LEU
82
n
8
LEU
82
B
GLU
83
n
9
GLU
83
B
PRO
84
n
10
PRO
84
B
TYR
85
n
11
TYR
85
B
PRO
86
n
12
PRO
86
B
ASP
87
n
13
ASP
87
B
author_and_software_defined_assembly
PISA
2
dimeric
1220
-8
5530
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
THR
5
A
N
THR
5
A
O
SER
12
A
O
SER
12
A
N
CYS
60
A
N
CYS
60
A
O
CYS
23
A
O
CYS
23
A
N
ASP
30
A
N
ASP
30
A
O
GLY
37
A
O
GLY
37
A
N
VAL
40
A
N
VAL
40
B
O
TYR
77
B
O
TYR
3
1
A
A
O
H
ASP
PHE
30
32
1.39
1
A
A
H
O
ASP
GLY
30
37
1.59
1
A
A
O
N
ASP
PHE
30
32
1.97
2
A
A
O
H
ASP
PHE
30
32
1.31
2
A
B
H
O
VAL
TYR
40
77
1.56
2
A
A
H
O
ASP
GLY
30
37
1.60
2
A
A
O
N
ASP
PHE
30
32
1.97
3
A
A
O
H
ASP
PHE
30
32
1.32
3
A
A
O
H
ASP
CYS
63
65
1.52
3
A
A
H
O
ASP
GLY
30
37
1.53
3
A
A
O
H
TRP
VAL
28
39
1.55
3
A
A
H
O
THR
SER
5
12
1.59
3
A
A
O
N
ASP
PHE
30
32
1.97
4
A
A
O
H
ASP
PHE
30
32
1.58
4
A
A
O
N
ASP
PHE
30
32
2.02
4
A
A
O
N
PHE
SER
32
34
2.07
5
A
A
O
H
ASP
PHE
30
32
1.35
5
A
A
H
O
ASP
GLY
30
37
1.59
5
A
A
O
H
TRP
VAL
28
39
1.59
5
A
A
O
N
ASP
PHE
30
32
1.98
6
A
A
O
H
ASP
PHE
30
32
1.44
6
A
B
H
O
VAL
TYR
40
77
1.55
6
A
A
H
O
ASP
GLY
30
37
1.59
6
A
A
O
H
TRP
VAL
28
39
1.59
6
A
A
O
N
ASP
PHE
30
32
1.97
7
A
A
O
H
ASP
PHE
30
32
1.41
7
A
A
H
O
ASP
GLY
30
37
1.58
7
A
A
O
H
TRP
VAL
28
39
1.59
7
A
A
O
N
ASP
PHE
30
32
1.97
8
A
A
O
H
ASP
PHE
30
32
1.41
8
A
A
O
H
TRP
VAL
28
39
1.49
8
A
B
H
O
VAL
TYR
40
77
1.55
8
A
A
O
N
ASP
PHE
30
32
1.97
9
A
A
H
O
ASP
GLY
30
37
1.55
9
A
A
O
N
ASP
PHE
30
32
2.08
10
A
A
O
H
ASP
PHE
30
32
1.40
10
A
A
O
N
ASP
PHE
30
32
1.98
1
A
ALA
7
-90.16
43.40
1
A
PRO
18
-49.73
79.00
1
A
TRP
28
-170.45
122.78
1
A
CYS
29
-58.40
109.98
1
A
ALA
31
-35.64
58.19
1
A
PHE
32
-172.50
23.81
1
A
CYS
33
-39.40
-26.69
1
A
SER
35
-90.03
-80.41
1
A
ARG
36
-69.37
-81.60
1
A
LYS
38
-45.21
105.33
1
A
LYS
64
38.85
34.56
1
A
ASN
66
-114.87
52.72
2
A
PRO
18
-61.06
67.05
2
A
TRP
28
-170.27
121.27
2
A
ALA
31
-36.59
55.53
2
A
PHE
32
-172.95
28.14
2
A
CYS
33
-37.89
-28.12
2
A
SER
35
-91.32
-80.47
2
A
ARG
36
-69.01
-80.79
2
A
LYS
38
-39.85
106.15
2
A
TYR
54
-178.17
-51.36
2
A
GLU
55
-119.30
52.55
2
A
GLU
56
-160.28
-168.81
2
A
SER
61
-111.28
55.79
2
B
SER
80
-52.76
-78.25
3
A
TRP
28
-170.61
124.98
3
A
CYS
29
-42.58
108.93
3
A
ALA
31
-36.05
54.84
3
A
PHE
32
-173.19
26.55
3
A
CYS
33
-37.66
-28.60
3
A
SER
35
-94.85
-74.12
3
A
ARG
36
-69.16
-81.69
3
A
LYS
38
-39.59
104.41
3
A
PRO
49
-66.78
-177.99
3
A
THR
62
-109.18
61.02
3
A
ASP
63
53.04
-158.10
3
A
LYS
64
-61.53
65.41
3
A
ASN
66
-109.89
57.20
3
A
HIS
68
-39.81
137.44
4
A
PRO
18
-58.74
72.79
4
A
TRP
28
-170.60
123.15
4
A
ALA
31
-36.49
66.18
4
A
PHE
32
-171.22
-23.07
4
A
CYS
33
14.78
-61.14
4
A
SER
35
-85.56
-83.27
4
A
ARG
36
-69.53
-80.95
4
A
LYS
38
-45.73
103.84
4
A
THR
47
-162.62
8.65
4
A
CYS
48
-39.62
97.50
4
A
LYS
51
-162.69
35.12
4
A
LYS
52
-170.51
90.55
4
A
PRO
53
-66.33
60.65
4
A
TYR
54
171.60
-28.88
4
A
LYS
64
32.21
43.49
4
A
ASN
66
-116.56
51.62
4
A
GLN
71
-95.26
46.19
4
A
PRO
73
-73.25
-167.85
5
A
TRP
28
-170.53
121.26
5
A
ALA
31
-36.54
57.16
5
A
PHE
32
-172.50
26.33
5
A
SER
35
-99.07
-75.27
5
A
ARG
36
-69.46
-83.09
5
A
LYS
38
-39.83
106.75
5
A
SER
50
-170.05
132.72
5
A
LYS
51
-170.29
74.30
5
A
TYR
54
-154.56
84.26
5
A
SER
61
-154.73
35.32
5
A
ASP
63
59.48
145.05
5
A
LYS
64
23.04
41.20
5
A
ASN
66
-108.82
57.31
5
A
PRO
69
-68.71
76.41
5
A
LYS
70
172.67
-28.37
5
A
GLN
71
-45.69
162.92
6
A
PRO
18
-49.20
78.63
6
A
TRP
28
-170.53
121.86
6
A
CYS
29
-55.47
109.36
6
A
ALA
31
-35.57
60.93
6
A
PHE
32
-171.76
21.98
6
A
SER
35
-94.59
-85.45
6
A
ARG
36
-69.72
-78.60
6
A
LYS
38
-41.68
107.49
6
A
SER
50
-63.32
-174.94
6
A
TYR
54
-157.75
21.91
6
A
SER
61
-117.87
63.34
6
A
LYS
64
35.66
39.69
6
A
ASN
66
-115.89
50.78
6
A
GLN
71
-47.33
173.78
6
B
SER
81
-170.05
126.00
7
A
ALA
7
-90.13
39.21
7
A
TRP
28
-170.49
122.20
7
A
ALA
31
-35.89
59.51
7
A
PHE
32
-172.18
21.93
7
A
CYS
33
-39.48
-26.33
7
A
SER
35
-93.60
-80.47
7
A
ARG
36
-69.09
-80.56
7
A
LYS
38
-41.68
104.38
7
A
SER
50
-170.21
149.34
7
A
LYS
51
-170.07
45.87
7
A
LYS
64
35.92
39.24
7
A
ASN
66
-117.62
53.42
8
A
TRP
28
-170.74
131.60
8
A
ALA
31
-35.95
59.59
8
A
PHE
32
-172.12
20.71
8
A
CYS
33
-39.35
-26.92
8
A
SER
35
-95.49
-79.76
8
A
ARG
36
-69.58
-80.78
8
A
LYS
38
-41.15
108.34
8
A
SER
50
-170.36
146.30
8
A
LYS
51
-169.94
41.68
8
A
ASN
66
-113.70
54.61
8
A
ARG
72
-55.62
108.61
9
A
PRO
17
-55.90
-178.86
9
A
PRO
18
-69.24
63.19
9
A
TRP
28
-167.02
-109.85
9
A
ALA
31
-35.55
63.18
9
A
PHE
32
-172.92
-31.57
9
A
CYS
33
33.96
36.77
9
A
SER
34
-167.72
-73.98
9
A
ARG
36
-69.45
-78.05
9
A
TYR
54
172.59
-34.78
9
A
SER
61
-149.36
32.45
9
A
ASP
63
60.66
146.93
9
A
LYS
64
30.47
35.48
9
A
ASN
66
-110.48
53.86
9
A
LYS
70
179.14
-33.36
9
A
GLN
71
-50.54
175.82
10
A
TRP
28
-170.47
120.16
10
A
ALA
31
-35.96
58.85
10
A
PHE
32
-172.25
20.31
10
A
CYS
33
-34.80
-31.01
10
A
SER
35
-90.08
-79.17
10
A
ARG
36
-69.57
-82.12
10
A
LYS
38
-41.99
106.28
10
A
THR
47
-170.07
-166.95
10
A
PRO
49
-70.54
-165.02
10
A
GLU
55
-155.45
88.72
10
A
SER
61
-109.33
40.60
10
A
LYS
64
32.96
40.16
10
A
ASN
66
-114.02
52.38
10
A
PRO
73
-74.50
-167.89
ALPHA-BUNGAROTOXIN, PEPTIDE
A beta-Hairpin Structure in a 13-mer Peptide that Binds a-Bungarotoxin with High Affinity and Neutralizes its Toxicity
1
N
N
2
N
N
A
LYS
52
A
LYS
52
HELX_P
A
GLU
55
A
GLU
55
5
1
4
disulf
2.028
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
23
A
SG
CYS
23
1_555
disulf
2.029
A
CYS
16
A
SG
CYS
16
1_555
A
CYS
44
A
SG
CYS
44
1_555
disulf
2.043
A
CYS
29
A
SG
CYS
29
1_555
A
CYS
33
A
SG
CYS
33
1_555
disulf
2.029
A
CYS
48
A
SG
CYS
48
1_555
A
CYS
59
A
SG
CYS
59
1_555
disulf
2.029
A
CYS
60
A
SG
CYS
60
1_555
A
CYS
65
A
SG
CYS
65
1_555
TOXIN/PEPTIDE
TOXIN/PEPTIDE, COMPLEX (TOXIN-PEPTIDE), ACETYLCHOLINE RECEPTOR MIMITOPE, ALPHA-BUNGAROTOXIN, PROTEIN-PEPTIDE COMPLEX, TOXIN, BETA-HAIRPIN, TOXIN-PEPTIDE complex
NXL1_BUNMU
UNP
1
P01378
1HAJ
PDB
2
1HAJ
1
74
1HAJ
1
74
P01378
A
1
1
74
75
87
1HAJ
75
87
1HAJ
B
2
1
13
2
4
1
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
VAL
2
A
VAL
2
A
THR
5
A
THR
5
A
SER
12
A
SER
12
A
THR
15
A
THR
15
A
GLU
56
A
GLU
56
A
CYS
60
A
CYS
60
A
LEU
22
A
LEU
22
A
ASP
30
A
ASP
30
A
GLY
37
A
GLY
37
A
ALA
45
A
ALA
45
B
ARG
76
B
ARG
2
B
TYR
78
B
TYR
4
B
PRO
84
B
PRO
10
B
TYR
85
B
TYR
11
1
P 1